WAM
IDNA icon

Worth Asset Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Worth Asset Management’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$3K – 491
2022
Q3 		$3K Hold
100
– – ﹤0.01% 386
2022
Q2 		$3K Hold
100
– – ﹤0.01% 445
2022
Q1 		$3K Buy
+100
New +$3.53K ﹤0.01% 442

Other funds holding IDNA

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $6.46B AUM 18.45% 1-Year Est. Return

Worth Asset Management's IDNA Position: Q4 2022 in Review

Worth Asset Management sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q4 2022, closing a stake of 100 shares — an estimated $3K sold.

Worth Asset Management first reported a position in IDNA in Q1 2022 and held it in 3 quarters. The position peaked at $3K in Q3 2022. 75 funds tracked by Wall St. Rank hold IDNA as of Q4 2022.

  • Worth Asset Management reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q4 2022 after selling out during the quarter.
  • Worth Asset Management sold 100 iShares Genomics Immunology and Healthcare ETF shares in Q4 2022, an estimated $3K.
  • Worth Asset Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2022 and held it in 3 quarters.
  • Worth Asset Management's iShares Genomics Immunology and Healthcare ETF position peaked at $3K in Q3 2022.
  • 75 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2022.

Based on Worth Asset Management's 13F filing for Q4 2022, filed 13 Jan 2023.